More than a fifth of financial impact caused by cancer is linked to employees still working
The economic cost of people withdrawing from work - or experiencing complications - due to cancer, multiple sclerosis (MS), strokes and heart disease has been estimated to be up to £15.2bn a year by Legal & General's ‘Cost of Critical illness' report. Cancer and its impact on individuals in the UK workforce accounts for around £9.3bn worth of losses alone, said the research, while those with MS returning to work earn up to £8000 less each year. More than a fifth (22%) of the financial impact...
Over 50,000 diagnoses in the UK during 2018
Watch the full presentation
Aegon research shows
Tim Lewis on AIG's recent critical illness overhaul
Focus on quality rather than list of conditions